Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	20.16	0.17	1.29	0.83	0.07
Cash & Short-Term Investments	20.16	0.17	1.29	0.83	0.07
Cash Growth	11830.77%	-86.87%	54.69%	1018.46%	122.17%
Accounts Receivable	-	-	-	-	25.4
Other Receivables	-	-	-	18.4	-
Receivables	-	-	-	18.4	25.4
Other Current Assets	6.4	0.75	0.25	0.11	0.11
Total Current Assets	26.56	0.92	1.54	19.34	25.58
Long-Term Investments	238.44	54.43	88.53	69.53	94.92
Total Assets	920.18	568.22	548.28	549.5	542.51
Short-Term Debt	-	-	-	-	0.61
Other Current Liabilities	0.9	3.02	2.38	8.15	0.47
Total Current Liabilities	0.9	3.02	2.38	8.15	1.08
Total Liabilities	0.9	3.02	2.38	8.15	1.08
Common Stock	652.6	652.6	652.6	652.6	652.6
Retained Earnings	266.67	-87.4	-106.71	-111.26	-111.18
Shareholders' Equity	919.28	565.2	545.9	541.34	541.43
Total Liabilities & Equity	920.18	568.22	548.28	549.5	542.51
Total Debt	-	-	-	-	0.61
Net Cash (Debt)	20.16	0.17	1.29	0.83	-0.53
Net Cash Growth	11830.77%	-86.87%	54.69%	-	-
Net Cash Per Share	0.03	0.00	0.00	0.00	-0.00
Filing Date Shares Outstanding	588.9	652.6	652.6	652.6	652.6
Total Common Shares Outstanding	588.9	652.6	652.6	652.6	652.6
Working Capital	25.66	-2.1	-0.84	11.19	24.5
Book Value Per Share	1.56	0.87	0.84	0.83	0.83
Tangible Book Value	919.28	565.2	545.9	541.34	541.43
Tangible Book Value Per Share	1.56	0.87	0.84	0.83	0.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.